Literature DB >> 17890276

Clinical variability and characteristic autoantibody profile in primary C1q complement deficiency.

G Vassallo1, R W Newton, S E Chieng, M R Haeney, A Shabani, P D Arkwright.   

Abstract

OBJECTIVES: C1q deficiency is a rare inherited defect in the early part of the complement cascade. In this report, we describe the varied clinical features of patients with this condition as well as the characteristic autoantibody profile.
METHODS: A large Pakistani family with a high degree of consanguinity is described in which the father and five sons have C1q deficiency, all with different clinical manifestations.
RESULTS: Clinical features of C1q deficiency can vary from almost no disease to fulminant bacterial infection and localized lupus-like skin, renal or CNS disease. Autoantibodies to ribonucleoproteins such as anti-Sm and Ro, but not dsDNA, were present.
CONCLUSIONS: Awareness of the spectrum of clinical disease, autoantibody profiles and tests required to confirm the diagnosis of C1q deficiency are important if this life-threatening immunodeficiency disease is to be managed correctly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890276     DOI: 10.1093/rheumatology/kem207

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  10 in total

1.  C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.

Authors:  Deanna M Santer; Brian E Hall; Thaddeus C George; Stephanie Tangsombatvisit; Chih Long Liu; Peter D Arkwright; Keith B Elkon
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

Review 2.  Monogenic autoimmunity.

Authors:  Mickie H Cheng; Mark S Anderson
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 3.  Complement deficiencies in systemic lupus erythematosus.

Authors:  Angela R Bryan; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

Review 4.  Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.

Authors:  Hanna Kim; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky
Journal:  J Mol Med (Berl)       Date:  2016-09-27       Impact factor: 4.599

5.  Early Complement Component Deficiency in a Single-Centre Cohort of Pediatric Onset Lupus.

Authors:  Sagar Bhattad; Amit Rawat; Anju Gupta; Deepti Suri; Ravinder Garg; Martin de Boer; Taco W Kuijpers; Surjit Singh
Journal:  J Clin Immunol       Date:  2015-11-13       Impact factor: 8.317

6.  Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.

Authors:  Lucrezia Colonna; Graham C Parry; Sandip Panicker; Keith B Elkon
Journal:  Clin Immunol       Date:  2016-01-06       Impact factor: 3.969

7.  C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  Rosanne A van Schaarenburg; César Magro-Checa; Jaap A Bakker; Y K Onno Teng; Ingeborg M Bajema; Tom W Huizinga; Gerda M Steup-Beekman; Leendert A Trouw
Journal:  Front Immunol       Date:  2016-12-27       Impact factor: 7.561

8.  Neutrophil heterogeneity in complement C1q expression associated with sepsis mortality.

Authors:  Alissa Trzeciak; Raj Kumar Mongre; Ma Rie Kim; Kihong Lim; Rafael A Madero; Christopher N Parkhurst; Anthony P Pietropaoli; Minsoo Kim
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

9.  Cell surface expression and function of the macromolecular c1 complex on the surface of human monocytes.

Authors:  Kinga K Hosszu; Alisa Valentino; Yan Ji; Mara Matkovic; Lina Pednekar; Nina Rehage; Nithin Tumma; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Front Immunol       Date:  2012-03-05       Impact factor: 7.561

10.  The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: a case report.

Authors:  Yousuke Higuchi; Junya Shimizu; Michiyo Hatanaka; Etsuko Kitano; Hajime Kitamura; Hidetoshi Takada; Masataka Ishimura; Toshiro Hara; Osamu Ohara; Kenji Asagoe; Toshihide Kubo
Journal:  Pediatr Rheumatol Online J       Date:  2013-10-28       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.